Blood test could predict pregnancy complications October 13, 2020 -- A blood test commonly used to detect fetal genetic abnormalities may help predict complications associated with pregnancy before symptoms develop, according to new research published in Epigenetics on October 13. Genetic material shed from the placenta into the mother's blood during the first trimester of pregnancy could potentially be used to predict possibly serious complications.
Qiagen sales, earnings climb in Q3 October 13, 2020 -- Significant ongoing demand for COVID-19 testing and improved trends in other areas of Qiagen's product portfolio led to a 26% increase in preliminary net sales for the company during its third quarter.
Clinical labs face interruptions, staffing shortages October 9, 2020 -- The Association for Molecular Pathology has released the preliminary results of its August 2020 SARS-CoV-2 testing survey for clinical laboratories showing labs continue to experience supply chain interruptions and are now also facing significant staffing shortages. However, the demand for molecular diagnostic testing has increased. Discuss
Beckman Coulter nabs EUA for COVID-19 IgM assay October 9, 2020 -- The U.S. Food and Drug Administration has granted emergency use authorization (EUA) to Beckman Coulter's Access SARS-CoV-2 immunoglobulin M (IgM) assay, which detects antibodies that recognize the receptor-binding domain of the spike protein on the virus.
GenMark secures EUA for multiplex test October 9, 2020 -- The U.S. Food and Drug Administration has granted emergency use authorization (EUA) to GenMark Diagnostics for its ePlex respiratory test. The test provides results for more than 20 viruses and bacteria that can cause serious respiratory infections including COVID-19, the flu, bronchitis, and the common cold.
Natera prenatal test gets extended insurance coverage October 8, 2020 -- Healthcare insurer Centene has extended coverage of Natera's Panorama noninvasive prenatal test to all pregnant women. Panorama identifies a fetus's risk for severe genetic disorders as early as nine weeks into pregnancy.
Agilent updates Visiopharm image analysis software October 8, 2020 -- Agilent Technologies has released an updated version of its Visiopharm image analysis software. The software now incorporates HercepTest monoclonal antibody (mAb) pharmDx for Dako Omnis.
NIH, BARDA award $98.35M in COVID-19 testing contracts October 7, 2020 -- The U.S. National Institutes of Health (NIH), along with the Biomedical Advanced Research and Development Authority (BARDA), a U.S. federal health agency, has awarded $98.35 million in contracts for COVID-19 testing under the Rapid Acceleration of Diagnostics initiative.
Quidel gets EUA for combo flu, COVID-19 test October 6, 2020 -- Quidel has received a U.S. Food and Drug Administration emergency use authorization (EUA) for a rapid diagnostic that can simultaneously identify influenza A, influenza B, and the novel coronavirus.